SilverCrest Metals
SILV
Cars.com
CARS
Lantheus
LNTH
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -584.22%-5.42M | -80.40%843K | -474.05%-8.81M | 138.82%3.4M | 166.60%1.43M | 94.66%-792K | -70.23%4.3M | 82.78%-1.53M | -165.20%-8.77M | -92.79%536K |
Net income from continuing operations | 55.00%-2.89M | 77.60%-1.2M | 44.14%-2.05M | -202.41%-19.19M | -351.44%-3.76M | -195.32%-6.42M | -181.79%-5.35M | -192.30%-3.67M | 13.53%18.74M | -58.85%1.5M |
Operating gains losses | -183.66%-1.01M | -46.22%1.47M | 13.51%-890K | 155.32%2.45M | 286.12%1.11M | 40.03%-355K | 227.11%2.72M | 6.54%-1.03M | -21.71%-4.43M | 18.64%-598K |
Depreciation and amortization | 5.27%2.3M | 5.79%2.25M | 3.49%2.19M | 7.43%8.72M | 11.07%2.3M | 6.13%2.18M | 5.62%2.13M | 6.81%2.12M | 14.71%8.12M | 3.81%2.07M |
Deferred tax | -725.00%-75K | -89.17%13K | 500.00%40K | 431.73%553K | 806.56%431K | -88.46%12K | 73.91%120K | -25.00%-10K | -95.56%104K | -102.61%-61K |
Change In working capital | -257.99%-4.57M | -163.72%-2.4M | -6,900.76%-8.91M | 120.00%7.04M | 108.56%252K | 111.95%2.89M | -44.69%3.77M | 100.88%131K | -16.26%-35.18M | -195.09%-2.95M |
-Change in receivables | -119.11%-163K | -401.32%-2.29M | -176.12%-6.08M | 105.20%9.31M | -102.90%-288K | 282.26%853K | 3,400.00%759K | 262.40%7.98M | 146.52%4.54M | 404.88%9.94M |
-Change in inventory | 937.62%2.18M | -233.74%-325K | 50.89%-720K | 103.42%1.07M | 67.28%2.09M | 101.23%210K | 101.87%243K | 43.31%-1.47M | -153.30%-31.41M | 130.42%1.25M |
-Change in prepaid assets | -335.36%-4.51M | -196.22%-942K | -119.08%-375K | 81.30%-652K | 74.21%-2.56M | -163.73%-1.04M | -75.59%979K | 142.59%1.97M | -336.84%-3.49M | -465.55%-9.93M |
-Change in payables and accrued expense | -90.24%164K | 165.76%1.24M | 105.22%257K | 73.07%-2.06M | 199.16%3.06M | 115.69%1.68M | -114.11%-1.88M | 31.36%-4.92M | -6,579.66%-7.65M | -135.31%-3.08M |
-Change in other current assets | 32.84%1.08M | -94.76%24K | 106.16%65K | 188.96%419K | -79.80%200K | 214.13%816K | 213.09%458K | -209.38%-1.06M | 92.50%-471K | 117.19%990K |
-Change in other current liabilities | -1,008.20%-3.32M | -103.25%-104K | 13.30%-2.06M | -131.82%-1.05M | -6.40%-2.24M | -88.40%366K | 9.91%3.2M | -257.29%-2.38M | 386.45%3.3M | -2,322.99%-2.11M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -584.22%-5.42M | -80.40%843K | -474.05%-8.81M | 138.82%3.4M | 166.60%1.43M | 94.66%-792K | -70.23%4.3M | 82.78%-1.53M | -165.20%-8.77M | -92.79%536K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 125.45%454K | 76.76%-546K | -448.67%-3.91M | 89.68%-2.6M | 642.38%2.24M | 75.05%-1.78M | 80.55%-2.35M | 88.67%-713K | 35.01%-25.22M | 102.28%302K |
Net PPE purchase and sale | 78.55%-941K | 91.47%-271K | -21.46%-4.39M | 63.20%-10.48M | 134.33%703K | 44.56%-4.39M | 78.19%-3.18M | 42.55%-3.62M | 3.98%-28.47M | 102.84%300K |
Net investment purchase and sale | -46.39%1.4M | -133.25%-275K | -83.47%480K | 142.78%7.87M | 76,850.00%1.54M | 242.37%2.6M | -66.65%827K | --2.9M | 135.37%3.24M | 100.07%2K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 125.45%454K | 76.76%-546K | -448.67%-3.91M | 89.68%-2.6M | 642.38%2.24M | 75.05%-1.78M | 80.55%-2.35M | 88.67%-713K | 35.01%-25.22M | 102.28%302K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 43.80%824K | 140.91%1.68M | -65.36%2M | -77.35%8.61M | 131.17%6.37M | -95.67%573K | -129.06%-4.1M | -27.10%5.77M | 564.30%38.03M | 303.55%2.76M |
Net issuance payments of debt | 119.52%821K | 137.94%1.67M | -64.40%1.98M | -77.62%7.9M | 131.34%6.37M | -96.87%374K | -134.84%-4.41M | -29.76%5.56M | 965.54%35.28M | 390.04%2.75M |
Proceeds from stock option exercised by employees | --3K | 150.00%5K | 150.00%20K | -98.07%10K | --0 | --0 | -98.63%2K | --8K | -68.98%518K | -98.72%1K |
Net other financing activities | ---- | ---- | ---- | -68.29%708K | --0 | -78.35%199K | --306K | --203K | 200.13%2.23M | 100.05%1K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 43.80%824K | 140.91%1.68M | -65.36%2M | -77.35%8.61M | 131.17%6.37M | -95.67%573K | -129.06%-4.1M | -27.10%5.77M | 564.30%38.03M | 303.55%2.76M |
Net cash flow | ||||||||||
Beginning cash position | 1.74%41.6M | -11.79%39.6M | 21.20%50.11M | 12.47%41.35M | 6.74%39.3M | -9.03%40.89M | 52.21%44.89M | 12.47%41.35M | -49.36%36.76M | -15.57%36.82M |
Current changes in cash | -106.74%-4.14M | 191.78%1.98M | -403.97%-10.72M | 132.80%9.41M | 179.41%10.04M | 77.12%-2M | -113.06%-2.15M | 148.43%3.53M | 111.11%4.04M | 150.01%3.59M |
Effect of exchange rate changes | 220.14%1.34M | 101.13%21K | 973.68%204K | -219.19%-646K | -17.52%772K | -33.70%417K | -79.13%-1.85M | 58.33%19K | -1.63%542K | 174.49%936K |
End cash Position | -1.30%38.79M | 1.74%41.6M | -11.79%39.6M | 21.20%50.11M | 21.20%50.11M | 6.74%39.3M | -9.03%40.89M | 52.21%44.89M | 12.47%41.35M | 12.47%41.35M |
Free cash flow | -22.83%-6.36M | -49.11%572K | -156.27%-13.2M | 81.00%-7.07M | 155.02%2.13M | 77.24%-5.18M | 1,060.68%1.12M | 66.12%-5.15M | -12.99%-37.23M | 126.81%836K |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |